Medical Advisors
Review Team Structure
Section titled “Review Team Structure”HRT Pharmacopoeia’s medical content is reviewed by a cross-disciplinary volunteer team, assigned by topic:
| Domain | Review responsibility |
|---|---|
| Endocrinology | Estrogen / antiandrogen / progestin dosing, blood test interpretation, metabolism, and bone density |
| Psychiatry | Gender-affirming assessment, mood fluctuation, interactions with concurrent medications |
| Hepatology / Hematology | CPA hepatotoxicity, VTE risk, coagulation monitoring |
| Legal advisors | Mainland China prescribing compliance, privacy regulation, traveling internationally with medication |
Reviewer Roster
Section titled “Reviewer Roster”We respect each volunteer’s choice of identity. Advisors who consent to public attribution are listed below with name / ORCID / professional affiliation; those who prefer privacy are listed only by professional credential and department type, with no identifiable information disclosed.
Current status (2026-04-19)
The site is currently in a “community curation + cross-referenced international guidelines” phase, and has not yet contracted publicly named licensed physicians.
- All medical content is anchored to the following authoritative sources, each cited with a DOI:
- Endocrine Society 2017, Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons
- WPATH SOC 8 (2022)
- UCSF Transgender Care Guidelines
- EMA / FDA drug safety alerts
- Every medical claim must be accompanied by a
<CitationRef>pointing to the primary source - Page frontmatter mandates the three metadata fields
evidenceLevel,lastReviewed, andreferences
Next steps: We are reaching out to trans-friendly licensed physicians in mainland China, Hong Kong / Macau / Taiwan, Japan, and North America to join a rotating review pool. If you are interested, please contact us via the feedback form or GitHub.
Review Principles
Section titled “Review Principles”- No prescribing relationship: reviewers have no direct prescribing relationship to the medications or brands recommended on this site, to avoid conflicts of interest
- Dissent on file: review comments and editorial decisions are recorded throughout; major disagreements are publicly disclosed
- Identity protection: advisors may remain anonymous, but must provide the editorial team with a copy of their professional license and proof of affiliation
- Update obligation: within 48 hours of a major guideline update, reviewers confirm whether existing pages are affected